We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLM icon
551
Martin Marietta Materials
MLM
$33.6B
$962K 0.02%
4,408
-617
-12% -$136K
VAR
552
DELISTED
Varian Medical Systems, Inc.
VAR
$934K 0.02%
10,245
+2,604
+34% +$217K
XL
553
DELISTED
XL Group Ltd.
XL
$928K 0.02%
23,291
+3,773
+19% +$148K
EXPE icon
554
Expedia Group
EXPE
$31.2B
$925K 0.02%
7,331
+1,897
+35% +$232K
EG icon
555
Everest Group
EG
$15.2B
$923K 0.02%
3,946
+352
+10% +$80.4K
HII icon
556
Huntington Ingalls Industries
HII
$11.3B
$917K 0.02%
+4,577
New +$930K
VTVT icon
557
vTv Therapeutics
VTVT
$121M
$917K 0.02%
+3,500
New +$798K
AVT icon
558
Avnet
AVT
$7.33B
$915K 0.02%
20,000
– –
IVZ icon
559
Invesco
IVZ
$13.3B
$908K 0.02%
29,656
+6,905
+30% +$216K
PBA icon
560
Pembina Pipeline
PBA
$29.9B
$906K 0.02%
28,664
+2,367
+9% +$75.2K
RCI icon
561
Rogers Communications
RCI
$17.7B
$904K 0.02%
20,501
-20,158
-50% -$845K
BFH icon
562
Bread Financial
BFH
$4.21B
$895K 0.02%
4,506
+602
+15% +$114K
MAS icon
563
Masco
MAS
$16B
$891K 0.02%
26,222
+5,312
+25% +$177K
TDG icon
564
TransDigm Group
TDG
$69.2B
$872K 0.02%
3,960
+433
+12% +$103K
EEM icon
565
iShares MSCI Emerging Markets ETF
EEM
$28B
$871K 0.02%
22,109
– –
CBIO
566
Crescent Biopharma
CBIO
$602M
$869K 0.02%
1,600
– –
AUPH icon
567
Aurinia Pharmaceuticals
AUPH
$1.97B
$866K 0.02%
+118,000
New +$545K
DNB
568
DELISTED
Dun & Bradstreet
DNB
$863K 0.02%
7,995
– –
AXS icon
569
AXIS Capital
AXS
$8.59B
$862K 0.02%
12,854
– –
CHL
570
DELISTED
China Mobile Limited
CHL
$852K 0.02%
15,420
– –
RNR icon
571
RenaissanceRe
RNR
$13.7B
$850K 0.02%
5,877
+518
+10% +$74.1K
CPAY icon
572
Corpay
CPAY
$24.2B
$844K 0.02%
5,574
+1,582
+40% +$248K
QVCGA
573
DELISTED
QVC Group Inc Series A
QVCGA
$842K 0.02%
867
+128
+17% +$120K
ALB icon
574
Albemarle
ALB
$13.5B
$836K 0.02%
+7,910
New +$770K
KMX icon
575
CarMax
KMX
$8.27B
$836K 0.02%
14,118
+3,131
+28% +$203K
21 22
23
24 25

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.